Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by langostaon May 18, 2018 1:38pm

66 Views

Post# 28053534

RE:RE:RE:RE:RE:How many of the 9 patients we need to qualify to Phase 2 ?

I'm sure that the treatment of P7,8,9, will give us another boost, also the news and discussions coming out of the AGM, i.e. GBM and NSCLC will add recognition, (NSCLC always gets me, I keep getting confused with the Nova Scotia Liquor Commission). My personal opinion is that the 180 day report on P5 could be the rocket for TLT. As Laser has pointed out, The Right To Try legislation, coming soon courtesy of Donald, with its 97% of patients not in clinical trials, will light another fire under the tail of TLT. IT'S ALL GOOD.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide